(Q43878025)

27 November 2017

title

Neuropilin-1 is overexpressed in osteosarcoma and contributes to tumor progression and poor prognosis (English)

1 reference

27 November 2017

1 reference

1 reference

H Zhu

1

1 reference

27 November 2017

H Cai

series ordinal

2

1 reference

27 November 2017

M Tang

series ordinal

3

1 reference

27 November 2017

J Tang

series ordinal

4

1 reference

27 November 2017

publication date

12 December 2013

1 reference

Clinical and Translational Oncology

27 November 2017

published in

1 reference

27 November 2017

volume

16

1 reference

27 November 2017

issue

8

1 reference

27 November 2017

page(s)

732-738

1 reference

New targets and approaches in osteosarcoma.

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1141-Y

Relative tumor burden predicts metastasis-free survival in pediatric osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1141-Y

Prognostic markers in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1141-Y

Neuropilin is a receptor for the axonal chemorepellent Semaphorin III

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1141-Y

Neuropilins in physiological and pathological angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1141-Y

Neuropilins: expression and roles in the epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1141-Y

The neuropilin 1 cytoplasmic domain is required for VEGF-A-dependent arteriogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1141-Y

Expression of semaphorin 3A and neuropilin 1 with clinicopathological features and survival in human tongue cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1141-Y

Neuropilin-1 and neuropilin-2 expression in the adenoma-carcinoma sequence of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1141-Y

Clinical utility of biochemical bone turnover markers in children and adolescents with osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1141-Y

The level of vascular endothelial growth factor as a predictor of a poor prognosis in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1141-Y

Preoperative chemotherapy for osteogenic sarcoma:Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1141-Y

Increased expression of CD24 is associated with tumor progression and prognosis in patients suffering osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1141-Y

Neuropilin-1 is expressed by breast cancer stem-like cells and is linked to NF-κB activation and tumor sphere formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1141-Y

VEGF exerts an angiogenesis-independent function in cancer cells to promote their malignant progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1141-Y

Neuropilin-1 exerts co-receptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1141-Y

Targeting neuropilin 1 as an antitumor strategy in lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1141-Y

Semaphorin 3B inhibits the phosphatidylinositol 3-kinase/Akt pathway through neuropilin-1 in lung and breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1141-Y

Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodelling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-013-1141-Y

Differential expression of VEGF isoforms and VEGF receptors in cartilaginous tumors

21 January 2018

1 reference

12 December 2020

Neuropilin-1 expression in cancer and development

1 reference

12 December 2020

VEGFR1 and NRP1 endothelial expressions predict distant relapse after radical prostatectomy in clinically localized prostate cancer

1 reference

12 December 2020

Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols

1 reference

12 December 2020

Expression and significance of TGF-beta isoform and VEGF in osteosarcoma

1 reference

12 December 2020

Adjuvant chemotherapy in osteosarcoma: an odyssey of rejection and vindication

1 reference

12 December 2020

Cell-retained isoforms of vascular endothelial growth factor (VEGF) are correlated with poor prognosis in osteosarcoma

1 reference

12 December 2020

Neuropilin-2 expression affects the increased vascularization and is a prognostic factor in osteosarcoma

1 reference

12 December 2020

Noninvasive imaging with thallium-201 scintigraphy may not correlate with survival in patients with osteosarcoma

1 reference

12 December 2020

Osteosarcoma in adolescents and young adults: new developments and controversies. Commentary on pathology

1 reference

12 December 2020

10.1007/S12094-013-1141-Y

Identifiers

DOI

1 reference

27 November 2017

1 reference